Most importantly, our study explored the mechanism of action of CXCL10 and CXCL11 in the TME and immune cell infiltration of PAAD and provided information anticipated to facilitate pancreatic cancer immunotherapy. The gene discussed is CXCL11; the disease is pancreatic neoplasm.